Bendrofluazide (Bendroflumethiazide)


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 45.5%
Hypertension 25.0%
Product Used For Unknown Indication 12.5%
Gout 4.5%
Hiv Infection 4.5%
Diabetes Mellitus 3.4%
Blood Pressure Increased 1.1%
Depression 1.1%
Rheumatoid Arthritis 1.1%
Supraventricular Tachycardia 1.1%
Obesity 19.0%
Renal Failure Acute 9.5%
Asthenia 4.8%
Blood Osmolarity Decreased 4.8%
Coma 4.8%
Convulsion 4.8%
Drug Interaction 4.8%
Head Injury 4.8%
Hypokalaemia 4.8%
Hyponatraemia 4.8%
Mouth Ulceration 4.8%
Nephrolithiasis 4.8%
Renal Impairment 4.8%
Syncope 4.8%
Thrombocytopenia 4.8%
Urinary Hesitation 4.8%
Weight Fluctuation 4.8%
Concomitant
Hypertension 17.3%
Product Used For Unknown Indication 12.4%
Depression 9.2%
Renal Cell Carcinoma Stage Unspecified 5.9%
Hypercholesterolaemia 4.9%
Acute Myocardial Infarction 4.3%
Atrial Fibrillation 4.3%
Multiple Myeloma 4.3%
Pain 4.3%
Colorectal Cancer 3.8%
Schizophrenia 3.8%
Crohn's Disease 3.2%
Neuralgia 3.2%
Urinary Tract Infection 3.2%
Blood Pressure Increased 2.7%
Diabetes Mellitus 2.7%
Diabetes Mellitus Non-insulin-dependent 2.7%
Osteoporosis 2.7%
Rheumatoid Arthritis 2.7%
Chronic Lymphocytic Leukaemia 2.2%
Renal Failure Acute 14.3%
Wheezing 8.3%
Orthostatic Hypotension 6.0%
White Blood Cell Count Decreased 6.0%
Alanine Aminotransferase Increased 4.8%
Oedema 4.8%
Rhabdomyolysis 4.8%
Sepsis 4.8%
Swelling Face 4.8%
Tremor 4.8%
Vomiting 4.8%
Atrioventricular Block Complete 3.6%
Death 3.6%
Fatigue 3.6%
Lung Disorder 3.6%
Palpitations 3.6%
Somnolence 3.6%
Suicidal Ideation 3.6%
Systolic Hypertension 3.6%
Vision Blurred 3.6%

Drug Data